Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML

Clinical trial NCT07304232 · RECRUITING

Trial details

NCT number: NCT07304232
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Allogeneic Hematopoietic Cell Transplantation (HCT)AML (Acute Myeloid Leukemia)

Start date: 2025-09-01
Primary completion: 2026-12-31
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.